Incidence and Severity of SARS-CoV-2 Infections in People With Primary Ciliary Dyskinesia.

Autor:	Pedersen ESL; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Schreck LD; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Graduate School for Health Sciences, University of Bern, Bern, Switzerland., Goutaki M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland., Bellu S; Associazione Italiana Discinesia Ciliare Primaria Sindrome di Kartagener Onlus, Onlus, Italy., Copeland F; PCD Support UK, London, United Kingdom., Lucas JS; Primary Ciliary Dyskinesia Centre, NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; School of Clinical and Experimental Medicine, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Zwahlen M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Kuehni CE; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.
Jazyk:	angličtina
Zdroj:	International journal of public health [Int J Public Health] 2023 Aug 17; Vol. 68, pp. 1605561. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
DOI:	10.3389/ijph.2023.1605561
Abstrakt:	Objectives: There is little data on SARS-CoV-2 in people with rare chronic diseases. We studied incidence and severity of SARS-CoV-2 and its risk factors in people with primary ciliary dyskinesia (PCD) from May 2020 to May 2022. Methods: We used self-reported questionnaire data from the COVID-PCD study at baseline or during weekly follow-ups. We studied factors associated with SARS-CoV-2 and symptoms using Poisson regression. Results: By May 2022, 728 people participated (40% male, median age 27 years; range 0-85). 87 (12%) reported SARS-CoV-2 at baseline or during follow-up and 62 people reported an incident SARS-CoV-2 infection during 716 person-years (incidence rate 9 per 100 person years). The strongest predictors for reporting SARS-CoV-2 were exposure during periods where Delta variant was dominant (IRR 4.52, 95% CI 1.92-10.6) and Omicron variants (IRR 13.3, 95% CI 5.2-33.8). Severity was mild; 12 (14%) were asymptomatic and 75 (86%) had symptoms among whom four were hospitalized. None needed intensive care and nobody died. Conclusion: The COVID-PCD study participants did not have a higher incidence of SARS-CoV-2 infections nor higher risk of severe COVID-19 disease than people from the general population. Competing Interests: The authors declare that they do not have any conflicts of interest. (Copyright © 2023 Pedersen, Schreck, Goutaki, Bellu, Copeland, Lucas, Zwahlen and Kuehni.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu